Investing.com - Financial Markets Worldwide

Central Proteina Prima Tbk (CPRO)

Jakarta
Currency in IDR
51
+1(+2.00%)
Closed·

CPRO Financial Summary

Key Ratios

P/E Ratio7.97
Price/Book0.82
Debt / Equity46.27%
Return on Equity10.52%
Dividend Yield0.00%
EBITDA922.38B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Income Statement
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa7,573,5068,028,0788,242,3439,027,2769,280,242
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa1,332,5451,509,9151,639,2461,678,1991,835,726
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa666,630799,001823,048756,571824,000
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa380,9022,208,722373,668401,468319,976
Balance Sheet
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa6,326,2936,444,4386,833,7376,856,3386,706,321
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa5,085,0642,055,1511,981,6662,228,1822,366,954
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa707,5842,873,7413,181,8323,419,7033,568,651
Cash Flow
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa629,420.13-622,438.75-3,692.63141,551.75417,666.5
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa756,89299,209284,210323,485765,703
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-121,795-166,873-164,408-115,926-203,407
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-463,441-136,414-148,082-209,451-538,582
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa172,364-203,482-20,237-3,02124,448
* In Millions of IDR (except for per share items)

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
2.69 / --
Revenue / Forecast
2.40T / --
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What were Central Proteina's earnings for the latest quarter?

The Central Proteina EPS (TTM) is 6.40. Central Proteina reported sales of 2,395,307.00, net income of 159,975.00, and EPS of 2.69 for the latest quarter.

What was Central Proteina's net income for the latest quarter?

Central Proteina's net income for the latest quarter was 159,975.00.

How did Central Proteina's performance compare year-over-year in the latest quarter?

The company's revenue moved from 2,393,133.00 in the previous quarter to 2,395,307.00 in the latest quarter, and net income moved from -22,509.00 to 159,975.00 compared to the previous quarter.

What is Central Proteina's net profit margin on a TTM basis?

Central Proteina's trailing twelve months (TTM) net profit margin is 3.45%.

How does Central Proteina's debt to equity ratio compare to industry standards?

Central Proteina's total debt-to-equity ratio is 46.27%.

What is Central Proteina's return on investment on a TTM basis?

Central Proteina's trailing twelve months (TTM) return on investment (ROI) is 10.52%.

Did Central Proteina gain or lose cash last quarter?

In the latest quarter, Central Proteina's net change in cash was -40,790.00 million.

What were Central Proteina's total assets and liabilities in the latest quarter?

As of the latest quarter, Central Proteina reported total assets of 6,806,765.00 million and total liabilities of 2,348,652.00 million.

How has Central Proteina's total revenue grown this year?

Central Proteina's total revenue was 2,393,133.00 in the previous quarter and 2,395,307.00 in the latest quarter.

What is Central Proteina's gross margin on a TTM basis?

Central Proteina's trailing twelve months (TTM) gross margin is 20.41%.

What was Central Proteina's revenue per share for the latest quarter?

Central Proteina's revenue per share for the latest quarter was 2,541.34.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.